Xeris Biopharma Holdings, Inc.
XERS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1 | -$2 | -$9 | -$5 |
| Dep. & Amort. | $3 | $3 | $3 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $5 | $4 | $4 |
| Change in WC | $0 | -$7 | -$9 | -$0 |
| Other Non-Cash | $7 | $1 | $1 | $1 |
| Operating Cash Flow | $18 | $0 | -$10 | $2 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $10 |
| Other Inv. Act. | $0 | -$0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$0 | -$0 | $10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $0 | $0 | $0 |
| Stock Repurch. | -$9 | $8 | -$8 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $14 | $0 | $5 | $1 |
| Financing Cash Flow | $14 | $1 | -$3 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | $1 | -$13 | $12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59 | $58 | $76 | $63 |
| End Cash | $0 | $59 | $63 | $76 |
| Free Cash Flow | $18 | $10 | -$10 | $2 |